Press Release Digest: March 23–27, 2026
A quick scan of the most talked-about corporate announcements from the past week.
McDonald’s & Netflix team up for KPop Demon Hunters meals. Starting March 31, two new limited-time adult meals arrive at McDonald’s locations, with exclusive photocards and flavors inspired by the chain’s South Korean menu.
This is the latest in a string of entertainment-brand crossovers that McDonald’s has leaned into heavily since its “Famous Orders” celebrity meal era. What makes this one different is the cultural specificity — pulling menu items from South Korea rather than just slapping a logo on existing products signals a more sophisticated approach to the K-wave, and an acknowledgment that the franchise’s global menu is itself a marketing asset. For Netflix, it’s cheap, high-footprint promotion for a film that needs mainstream awareness beyond its core fanbase.
United Airlines introduces the Relax Row. A new Economy option on international routes lets a row of three seats convert into a lie-flat space after takeoff — targeting families, couples, and solo travelers who want more room without upgrading cabins.
The airline industry has long treated the gap between Economy and Business Class as a revenue moat, but carriers are increasingly realizing that upselling within Economy is more accessible to a broader customer base. United’s Relax Row is a smart middle-ground product — it doesn’t cannibalize premium cabins, but it does give travelers a reason to choose United over a competitor on a long-haul route. Expect other carriers to follow if uptake is strong.
Venmo opens up to 200M+ PayPal users. Venmo users can now send and receive money with PayPal accounts across 90 countries, marking the app’s biggest expansion of its addressable market since launch.
This is a significant strategic move that had been a long time coming. Venmo and PayPal have coexisted under the same corporate roof since 2013, yet operated largely as separate products competing for overlapping users. Opening the pipes between them turns Venmo from a domestic peer-to-peer app into a genuine international payments tool overnight — without building new infrastructure. The bigger question is whether this blurs the two brands enough to eventually merge them, or whether PayPal is simply trying to make Venmo stickier before a potential spinoff.
Oracle launches Fusion Agentic Applications. Built into Oracle Fusion Cloud, the new suite uses AI agents to make and execute decisions inside live business processes — accessing enterprise data, workflows, and approval chains autonomously.
Every major enterprise software vendor is racing to claim the “agentic AI” label right now, but Oracle’s announcement is notable because it goes beyond generating text or summaries — it positions AI as an active participant in transactional workflows, not just an advisor. For Oracle’s existing Fusion customer base, the pitch is compelling: the agent already has access to your data, your org chart, and your approval rules. The risk, as with all agentic enterprise tools, is liability when an autonomous system makes the wrong call inside a live business process.
Abbott closes Exact Sciences acquisition. The deal strengthens Abbott’s position in cancer diagnostics, with a focus on more predictive and personalized testing as global cancer rates continue to climb.
Exact Sciences built its reputation on Cologuard, the at-home colorectal cancer screening test that disrupted traditional colonoscopy workflows. For Abbott, the acquisition is less about any single product and more about owning a direct-to-patient diagnostics channel at a time when early detection is becoming a healthcare priority. The deal also gives Abbott a foothold in liquid biopsy and multi-cancer early detection — a field attracting enormous investment and likely to be one of the defining healthcare battlegrounds of the next decade.
Merck to acquire Terns Pharmaceuticals for ~$6.7B. At $53.00 per share in cash, the deal brings Terns’ clinical-stage oncology pipeline under Merck’s umbrella and is one of the larger biopharma moves of the quarter.
Merck has been under pressure to diversify its pipeline ahead of Keytruda’s patent cliff, and acquisitions like this one reflect that urgency. Paying a substantial premium for a clinical-stage company is a bet that Terns’ assets will validate in trials — a gamble, but a necessary one for a company that cannot afford to stand still. The deal also signals continued confidence in oncology as the dominant therapeutic category for large-cap pharma M&A, despite tightening regulatory scrutiny of drug pricing.
MGM goes all-inclusive on the Las Vegas Strip. Luxor and Excalibur now offer bundled packages covering hotel, dining, entertainment, and parking from $330 plus tax for two nights — a notable format shift for Vegas hospitality.
Las Vegas has historically resisted the all-inclusive model, preferring to disaggregate every cost to maximize per-guest spend. The fact that MGM is piloting this at two of its more value-oriented properties — rather than at Bellagio or Aria — suggests a deliberate play for budget-conscious travelers who have been squeezed by resort fees and add-on costs. If it works, it could pressure competitors to offer similar bundles, fundamentally changing how Vegas packages are marketed and priced.
Allegiant offers fee-free changes amid shutdown. The budget carrier introduced a temporary flexible booking policy for flights affected by the ongoing partial government shutdown.
For a carrier that built its entire business model around ancillary fees, waiving change and cancellation charges is not a trivial gesture. It speaks to how much uncertainty the shutdown is injecting into travel demand — particularly for leisure-focused routes where Allegiant operates. The move is also smart PR: it positions the airline as a consumer ally during a period of government-caused disruption, at minimal actual cost since most affected travelers will rebook rather than cancel outright.